4-tert-butyl-N-(2-fluoro-4-(2-(1-methyl-1H-pyrazol-4-yl)-3H-imidazo[4,5-b]pyridin-7-yl)benzyl)cyclohexanecarboxamide

ID: ALA4876918

PubChem CID: 121249963

Max Phase: Preclinical

Molecular Formula: C28H33FN6O

Molecular Weight: 488.61

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cn1cc(-c2nc3c(-c4ccc(CNC(=O)C5CCC(C(C)(C)C)CC5)c(F)c4)ccnc3[nH]2)cn1

Standard InChI:  InChI=1S/C28H33FN6O/c1-28(2,3)21-9-7-17(8-10-21)27(36)31-14-19-6-5-18(13-23(19)29)22-11-12-30-26-24(22)33-25(34-26)20-15-32-35(4)16-20/h5-6,11-13,15-17,21H,7-10,14H2,1-4H3,(H,31,36)(H,30,33,34)

Standard InChI Key:  UHPUEKMMMVHFPJ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 36 40  0  0  0  0  0  0  0  0999 V2000
    8.8447   -3.1449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5545   -3.5535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5534   -2.7345    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3227   -7.6436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3216   -8.4631    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0296   -8.8721    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7393   -8.4627    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7364   -7.6400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0278   -7.2347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0313   -9.6871    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3219  -10.0949    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3213  -10.9114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0294  -11.3209    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.7367  -10.0931    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7440  -10.9082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5215  -11.1532    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.9948  -10.4894    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5097   -9.8343    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.8120  -10.4821    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3007  -11.1365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0756  -10.8770    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.0682  -10.0598    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.2888   -9.8144    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7250   -9.5735    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4426   -7.2287    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    6.0254   -6.4175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7319   -6.0068    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.7294   -5.1896    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4359   -4.7789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0205   -4.7832    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.1435   -5.1904    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8479   -4.7832    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8497   -3.9657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1409   -3.5570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4304   -3.9659    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2651   -3.9668    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 15  1  0
 14 10  1  0
  6 10  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 14  1  0
 17 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 23 19  2  0
 22 24  1  0
  8 25  1  0
  9 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 28 30  2  0
 29 31  1  0
 29 35  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 33  2  1  0
  2 36  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4876918

    ---

Associated Targets(Human)

BTK Tclin Tyrosine-protein kinase BTK (8973 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 488.61Molecular Weight (Monoisotopic): 488.2700AlogP: 5.63#Rotatable Bonds: 5
Polar Surface Area: 88.49Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.37CX Basic pKa: 1.96CX LogP: 5.03CX LogD: 5.03
Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.38Np Likeness Score: -1.59

References

1. Qiu H, Ali Z, Bender A, Caldwell R, Chen YY, Fang Z, Gardberg A, Glaser N, Goettsche A, Goutopoulos A, Grenningloh R, Hanschke B, Head J, Johnson T, Jones C, Jones R, Kulkarni S, Maurer C, Morandi F, Neagu C, Poetzsch S, Potnick J, Schmidt R, Roe K, Viacava Follis A, Wing C, Zhu X, Sherer B..  (2021)  Discovery of potent and selective reversible Bruton's tyrosine kinase inhibitors.,  40  [PMID:33932711] [10.1016/j.bmc.2021.116163]

Source